Preliminary results of the Prostacox phase II trial in hormonal refractory prostate cancer. [electronic resource]
Producer: 20071127Description: 770-4 p. digitalISSN:- 1464-4096
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Celecoxib
- Docetaxel
- Humans
- Male
- Middle Aged
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Pyrazoles -- administration & dosage
- Quality of Life
- Sulfonamides -- administration & dosage
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.